What Is GxP? A Plain-Language Definition for Non-Specialists
GxP is an umbrella term for the Good Practice quality regulations that govern medicinal products. The x stands in for the discipline: GMP for manufacturing, GCP for clinical trials, GLP for non-clinical laboratory studies, GDP for distribution and GVP for pharmacovigilance. Each is enforced by the regulator of the market you intend to supply.
What does the x in GxP stand for?
The x is a placeholder for the practice being governed, not an abbreviation in its own right. GMP covers manufacture and control of the finished product. GCP covers the design, conduct and reporting of trials involving human subjects. GLP covers non-clinical safety studies. GDP covers storage and transport through the supply chain. GVP covers safety monitoring once a product is on the market. A single organisation is usually in scope for several at once: a company running a trial with material it manufactures itself is bound by GCP and GMP simultaneously, and by GVP the moment it holds safety data.
Who enforces GxP, and does it differ by market?
There is no single global GxP regulation. The FDA enforces its requirements through 21 CFR, the EU through EudraLex Volume 4 and the associated directives, and other markets through their own instruments. The underlying expectations converge heavily — ICH guidelines such as Q7, Q9 and Q10 exist precisely to harmonise them — but the inspection style, the documentation the inspector expects to be handed, and the consequences of a finding are not identical. Assuming an FDA-ready dossier is EMA-ready is one of the most common and most expensive errors in cross-market filing.
Key takeaway
GxP is not paperwork you add at the end. It is the set of controls that make your data defensible, and it has to be designed in from the first study.
Why do organisations fail GxP inspections?
Rarely because a requirement was unknown. The recurring pattern is that quality was treated as a documentation exercise applied after the science was finished, rather than as a system that governs how the science is done. Data integrity findings — incomplete audit trails, records that cannot be reconstructed, results reviewed by nobody independent — dominate because they reveal the gap between what a procedure says and what the organisation actually did. An inspector is not auditing your intentions; they are auditing your evidence.
Frequently asked questions
Is GxP a law?
No. GxP is a shorthand for a family of regulations and guidelines. The legal force comes from the specific instrument in each market — 21 CFR in the United States, EudraLex Volume 4 in the European Union — not from the term GxP itself.
Does a small biotech need a full GxP quality system?
It needs a system proportionate to what it actually does. A company that outsources manufacture still carries responsibility for oversight of that contractor, and regulators will ask to see how that oversight was exercised. Scale the system, not the accountability.
What is the difference between GxP and ISO 9001?
ISO 9001 is a general quality management standard that an organisation adopts voluntarily and is certified against. GxP requirements are imposed by medicines regulators, are specific to medicinal products, and are enforced by inspection with the power to stop a product reaching the market.
Sources
- EudraLex Volume 4 — Good Manufacturing Practice guidelines, European Commission. health.ec.europa.eu
- ICH Q10 Pharmaceutical Quality System, International Council for Harmonisation. ich.org
Building or remediating a quality system?
Our consultants have built GxP systems for companies filing on both sides of the Atlantic, and have sat on the other side of the table as inspectors.
Explore GxP Quality Systems ➔